Clinical trial
Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries
NCT00195195 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195195 |
|---|---|
| Title | Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries |
| Official title | A Rapamune Follow-up Registry in Transplant Recipients in the Nordic Countries, "Wrap-up" |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Transplantation |
| Intervention type | Drug |
| Interventions | Sirolimus |
| Enrollment | 66 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 31, 2012 |
| Countries | Sweden |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: